{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T21:19:19Z","timestamp":1782249559446,"version":"3.54.5"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Among children with HIV infection, opportunistic illness (OI) rates decreased after introduction of highly active antiretroviral therapy (ART) in 1997. We evaluated whether such decreases have continued.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Data from the Centers for Disease Control and Prevention\u2019s National HIV Surveillance System for children with HIV living in the US during 1997\u20132016 was used to enumerate infants experiencing the first OI by birth year and OIs among all children &lt;13 years of age (stratified by natality). We calculated the time to first OI among infants using Kaplan-Meier methods.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Among infants born during 1997\u20132016, 711 first OIs were diagnosed. The percentage of the first OIs diagnosed in successive 5-year birth periods was: 60.0% (1997\u20132001), 24.6% (2002\u20132006), 11.3% (2007\u20132011), and 3.4% (2012\u20132016). For every OI, the number of first cases decreased nearly annually. Time to first OI increased in successive birth periods. Among children &lt;13 years of age, 2083 OI were diagnosed, including <jats:italic toggle=\"yes\">Pneumocystis jiroveci<\/jats:italic> pneumonia, candidiasis, recurrent bacterial infection, wasting syndrome, cytomegalovirus, lymphocytic interstitial pneumonitis, tuberculosis, nontuberculous mycobacteriosis and herpes simplex virus. The rate (#\/1000 person-years) decreased overall (60\u20137.2) and for all individual OIs. Earlier during 1997\u20132016, rates for all OIs were higher among foreign-born than US-born children but later became similar for all OIs except tuberculosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Among children with HIV in the US, numbers and rates of all OIs decreased during 1997\u20132016. Earlier, OI rates were highest among non-US-born children but were later comparable with those among US-born children for all OIs except tuberculosis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000003154","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T04:04:19Z","timestamp":1619496259000},"page":"645-648","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Opportunistic Illnesses in Children With HIV Infection in the United States, 1997\u20132016"],"prefix":"10.1097","volume":"40","author":[{"given":"Steven R.","family":"Nesheim","sequence":"first","affiliation":[{"name":"From the Division of HIV\/AIDS Prevention (DHAP), Centers for Disease Control and Prevention (CDC), National Center for HIV\/AIDS, Viral Hepatitis, Sexually Transmitted Diseases and Tuberculosis Prevention (NCHHSTP)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Balaji","sequence":"additional","affiliation":[{"name":"From the Division of HIV\/AIDS Prevention (DHAP), Centers for Disease Control and Prevention (CDC), National Center for HIV\/AIDS, Viral Hepatitis, Sexually Transmitted Diseases and Tuberculosis Prevention (NCHHSTP)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Hu","sequence":"additional","affiliation":[{"name":"From the Division of HIV\/AIDS Prevention (DHAP), Centers for Disease Control and Prevention (CDC), National Center for HIV\/AIDS, Viral Hepatitis, Sexually Transmitted Diseases and Tuberculosis Prevention (NCHHSTP)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Lampe","sequence":"additional","affiliation":[{"name":"From the Division of HIV\/AIDS Prevention (DHAP), Centers for Disease Control and Prevention (CDC), National Center for HIV\/AIDS, Viral Hepatitis, Sexually Transmitted Diseases and Tuberculosis Prevention (NCHHSTP)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth L.","family":"Dominguez","sequence":"additional","affiliation":[{"name":"From the Division of HIV\/AIDS Prevention (DHAP), Centers for Disease Control and Prevention (CDC), National Center for HIV\/AIDS, Viral Hepatitis, Sexually Transmitted Diseases and Tuberculosis Prevention (NCHHSTP)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,4,21]]},"reference":[{"key":"R1-20250615","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1001\/jama.1983.03330410031024","article-title":"Immune deficiency syndrome in children.","volume":"249","author":"Oleske","year":"1983","journal-title":"JAMA"},{"key":"R2-20250615","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1001\/jama.1983.03330410036025","article-title":"Acquired immunodeficiency with reversed T4\/T8 ratios in infants born to promiscuous and drug-addicted mothers.","volume":"249","author":"Rubinstein","year":"1983","journal-title":"JAMA"},{"key":"R3-20250615","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM198401123100202","article-title":"Acquired immunodeficiency syndrome in children.","volume":"310","author":"Scott","year":"1984","journal-title":"NEJM"},{"key":"R4-20250615","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1001\/jama.1993.03510040074032","article-title":"Pneumocystis carinii pneumonia among US children with perinatally acquired HIV infection.","volume":"270","author":"Simonds","year":"1993","journal-title":"JAMA"},{"key":"R5-20250615","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1056\/NEJM199503233321206","article-title":"Prophylaxis against cmmunodeficiency virus infection in the United States.","volume":"332","author":"Simonds","year":"1995","journal-title":"NEJM"},{"key":"R6-20250615","first-page":"609","article-title":"Perinatally acquired human immunodeficiency virus infection.","volume":"9","author":"Oxtoby","year":"1990","journal-title":"Pediatr Infect Dis J"},{"key":"R7-20250615","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1651-2227.1994.tb13335.x","article-title":"The opportunistic and bacterial infections associated with pediatric human immunodeficiency virus disease.","volume":"400","author":"Nicholas","year":"1994","journal-title":"Acta Paediatr Suppl"},{"key":"R8-20250615","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1001\/jama.282.6.531","article-title":"Trends in perinatal transmission of HIV\/AIDS in the United States.","volume":"282","author":"Lindegren","year":"1999","journal-title":"JAMA"},{"key":"R9-20250615","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1001\/jama.1992.03490040059026","article-title":"Prophylactic intravenous immunoglobulin in HIV-infected children with CD4+ counts of 0.20 x 10(9)\/L or more. Effect on viral, opportunistic, and bacterial infections. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.","volume":"268","author":"Mofenson","year":"1992","journal-title":"JAMA"},{"key":"R10-20250615","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1542\/peds.2006-2052","article-title":"Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.","volume":"120","author":"Nesheim","year":"2007","journal-title":"Pediatrics"},{"key":"R11-20250615","first-page":"40","article-title":"Correlates of opportunistic infections in children infected with human immunodeficiency virus managed before highly active antiretroviral therapy.","volume":"20","author":"Dankner","year":"2001","journal-title":"PIDJ"},{"key":"R12-20250615","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1001\/jama.296.3.292","article-title":"Incidence of opportunistic and other infections in HIV-infected children in the HAART era.","volume":"296","author":"Gona","year":"2006","journal-title":"JAMA"},{"key":"R13-20250615","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.3201\/eid1010.030985","article-title":"Current epidemiology of Pneumocystis pneumonia.","volume":"10","author":"Morris","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"R14-20250615","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/cid\/cir950","article-title":"Short- and long-term immunological and virological outcome in HIV-infected infants according to the age at antiretroviral treatment initiation.","volume":"54","author":"Goetghebuer","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R15-20250615","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1155\/2014\/526019","article-title":"Prevention of vertical HIV transmission and management of the HIV-exposed infant in Canada in 2014.","volume":"25","author":"Bitnun","year":"2014","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"R16-20250615","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/cid\/civ687","article-title":"Changing trends in complications and mortality rates among us youth and young adults with HIV infection in the era of combination antiretroviral therapy.","volume":"61","author":"Mirani","year":"2015","journal-title":"Clin Infect Dis"},{"key":"R17-20250615","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/jamapediatrics.2017.0141","article-title":"Association of risk of viremia, immunosuppression, serious clinical events, and mortality with increasing age in perinatally human immunodeficiency virus-infected youth.","volume":"171","author":"Neilan","year":"2017","journal-title":"JAMA Pediatr"},{"key":"R18-20250615","first-page":"1","article-title":"Revised surveillance case definition for HIV infection\u2014United States, 2014.","volume":"63","year":"2014","journal-title":"MMWR"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003154","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:02:29Z","timestamp":1750003349000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,21]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003154","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,21]]}}}